1. Home
  2. EXEL vs ORI Comparison

EXEL vs ORI Comparison

Compare EXEL & ORI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • ORI
  • Stock Information
  • Founded
  • EXEL 1994
  • ORI 1923
  • Country
  • EXEL United States
  • ORI United States
  • Employees
  • EXEL N/A
  • ORI N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • ORI Property-Casualty Insurers
  • Sector
  • EXEL Health Care
  • ORI Finance
  • Exchange
  • EXEL Nasdaq
  • ORI Nasdaq
  • Market Cap
  • EXEL 9.8B
  • ORI 9.3B
  • IPO Year
  • EXEL 2000
  • ORI N/A
  • Fundamental
  • Price
  • EXEL $43.04
  • ORI $37.79
  • Analyst Decision
  • EXEL Buy
  • ORI Buy
  • Analyst Count
  • EXEL 18
  • ORI 1
  • Target Price
  • EXEL $38.76
  • ORI $43.00
  • AVG Volume (30 Days)
  • EXEL 3.9M
  • ORI 1.2M
  • Earning Date
  • EXEL 05-13-2025
  • ORI 07-24-2025
  • Dividend Yield
  • EXEL N/A
  • ORI 8.23%
  • EPS Growth
  • EXEL 237.58
  • ORI 19.19
  • EPS
  • EXEL 2.20
  • ORI 3.04
  • Revenue
  • EXEL $2,298,922,000.00
  • ORI $8,329,500,000.00
  • Revenue This Year
  • EXEL $10.39
  • ORI $8.35
  • Revenue Next Year
  • EXEL $10.74
  • ORI $6.23
  • P/E Ratio
  • EXEL $19.53
  • ORI $12.43
  • Revenue Growth
  • EXEL 24.49
  • ORI 10.83
  • 52 Week Low
  • EXEL $20.40
  • ORI $29.51
  • 52 Week High
  • EXEL $48.85
  • ORI $39.84
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 59.93
  • ORI 50.42
  • Support Level
  • EXEL $42.21
  • ORI $37.10
  • Resistance Level
  • EXEL $43.75
  • ORI $37.87
  • Average True Range (ATR)
  • EXEL 1.60
  • ORI 0.54
  • MACD
  • EXEL -0.09
  • ORI -0.05
  • Stochastic Oscillator
  • EXEL 53.96
  • ORI 47.83

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About ORI Old Republic International Corporation

Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.

Share on Social Networks: